TheTechno Optimist.

StoryOther2023

Junevity founded as UCSF spinout to develop cell reprogramming therapeutics

Junevity was founded from research at UCSF, focusing on cell reprogramming therapeutics using siRNA and the RESET platform to target transcription factors.

Read the original · Press Longevity

More on Junevity

Junevity publishes PNAS paper showing single transcription-factor silencing reverses aging hallmarksJan 2026
Junevity expands seed funding to $20 million for JUN_01 obesity programDec 2025
Junevity closes $10M seed funding led by Goldcrest CapitalFeb 2025